Claudin expression is dysregulated in prostate adenocarcinomas but does not correlate with main clinicopathological parameters

被引:19
作者
Coutinho-Camillo, Claudia Malheiros [1 ]
Lourenco, Silvia Vanessa [3 ]
da Fonseca, Francisco Paulo [2 ]
Soares, Fernando Augusto [1 ,3 ]
机构
[1] Hosp AC Camargo Fund Antonio Prudente, Dept Anat Patol, BR-01509010 Sao Paulo, Brazil
[2] Hosp AC Camargo Fund Antonio Prudente, Div Urol, Dept Pelv Surg, BR-01509010 Sao Paulo, Brazil
[3] Univ Sao Paulo, Sch Dent, Discipline Gen Pathol, Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
Claudins; immunohistochemistry; prostate cancer; tissue microarray; TIGHT JUNCTION PROTEINS; HUMAN COLORECTAL-CANCER; PANCREATIC-CANCER; BREAST; INVASION; THERAPY; TARGETS; LESIONS; BENIGN; GRADE;
D O I
10.1097/PAT.0b013e3283428099
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aims: Claudins, a large family of essential tight junction (TJ) proteins, are abnormally regulated in human carcinomas. The aim of this study was to determine the expression of claudins 1, 2, 3, 4, 5, 7, and 11 in prostate samples from Brazilian patients and correlate it with the clinicopathological features of prostate cancer. Methods: Using a tissue microarray (TMA) of specimens of prostate adenocarcinoma and benign prostatic hyperplasia (BPH) we analysed the expression of claudins 1, 2, 3, 4, 5, 7, and 11 by immunohistochemistry. Results: Claudin 4 was down-regulated and claudins 2, 3, and 5 were overexpressed in prostate adenocarcinomas compared with BPH samples. Expression of claudins 1 and 7 was similar in tumours and BPH samples. Claudin 11 was absent from all prostate samples. Overexpression of claudin 3 was associated with perineural invasion (p = 0.014) and tended to occur in advanced stages of the disease (p = 0.064). Increased expression of claudin 5 was marginally associated with perineural invasion (p = 0.060). Conclusions: Our results suggest that alterations in claudin expression occur in prostate cancer cells, although we have not found an association with the main clinicopathological parameters.
引用
收藏
页码:143 / 148
页数:6
相关论文
共 29 条
  • [1] Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity
    Agarwal, R
    D'Souza, T
    Morin, P
    [J]. CANCER RESEARCH, 2005, 65 (16) : 7378 - 7385
  • [2] Anderson JM, 2001, NEWS PHYSIOL SCI, V16, P126
  • [3] Claudins upregulation in human colorectal cancer
    de Oliveira, SS
    de Oliveira, IM
    De Souza, W
    Morgado-Díaz, JA
    [J]. FEBS LETTERS, 2005, 579 (27) : 6179 - 6185
  • [4] Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer
    Dhawan, P
    Singh, AB
    Deane, NG
    No, Y
    Shiou, SR
    Schmidt, C
    Neff, J
    Washington, MK
    Beauchamp, RD
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (07) : 1765 - 1776
  • [5] Claudin-1 and -2: Novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin
    Furuse, M
    Fujita, K
    Hiiragi, T
    Fujimoto, K
    Tsukita, S
    [J]. JOURNAL OF CELL BIOLOGY, 1998, 141 (07) : 1539 - 1550
  • [6] Tight junction proteins
    González-Mariscal, L
    Betanzos, A
    Nava, P
    Jaramillo, BE
    [J]. PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 2003, 81 (01) : 1 - 44
  • [7] Expression and targeting of the tight junction protein CLDN1 in CLDN1-negative human breast tumor cells
    Hoevel, T
    Macek, R
    Mundigl, O
    Swisshelm, K
    Kubbies, M
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2002, 191 (01) : 60 - 68
  • [8] Cancer statistics, 2007
    Jemal, Ahmedin
    Siegel, Rebecca
    Ward, Elizabeth
    Murray, Taylor
    Xu, Jiaquan
    Thun, Michael J.
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2007, 57 (01) : 43 - 66
  • [9] Kominsky Scott L., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000056
  • [10] Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast
    Kominsky, SL
    Argani, P
    Korz, D
    Evron, E
    Raman, V
    Garrett, E
    Rein, A
    Sauter, G
    Kallioniemi, OP
    Sukumar, S
    [J]. ONCOGENE, 2003, 22 (13) : 2021 - 2033